Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 2016; Volume 89,Issue 5

Perspective

  • You have access
    The Molecular Pharmacology of G Protein Signaling Then and Now: A Tribute to Alfred G. Gilman
    Roger K. Sunahara and Paul A. Insel
    Molecular Pharmacology May 2016, 89 (5) 585-592; DOI: https://doi.org/10.1124/mol.116.104216

Accelerated Communication

  • You have access
    Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
    Koichiro Mihara, Rithwik Ramachandran, Mahmoud Saifeddine, Kristina K. Hansen, Bernard Renaux, Danny Polley, Stacy Gibson, Christina Vanderboor and Morley D. Hollenberg
    Molecular Pharmacology May 2016, 89 (5) 606-614; DOI: https://doi.org/10.1124/mol.115.102723

Articles

  • You have access
    Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor
    Dong Guo, Albert C. Pan, Ron O. Dror, Tamara Mocking, Rongfang Liu, Laura H. Heitman, David E. Shaw and Adriaan P. IJzerman
    Molecular Pharmacology May 2016, 89 (5) 485-491; DOI: https://doi.org/10.1124/mol.115.102657
  • You have access
    Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model
    Shannon Dallas, Laurent Salphati, David Gomez-Zepeda, Thomas Wanek, Liangfu Chen, Xiaoyan Chu, Jeevan Kunta, Mario Mezler, Marie-Claude Menet, Stephanie Chasseigneaux, Xavier Declèves, Oliver Langer, Esaie Pierre, Karen DiLoreto, Carolin Hoft, Loic Laplanche, Jodie Pang, Tony Pereira, Clara Andonian, Damir Simic, Anja Rode, Jocelyn Yabut, Xiaolin Zhang and Nico Scheer
    Molecular Pharmacology May 2016, 89 (5) 492-504; DOI: https://doi.org/10.1124/mol.115.102079
  • You have access
    Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein–Coupled Receptor 120
    Rudi Prihandoko, Elisa Alvarez-Curto, Brian D. Hudson, Adrian J. Butcher, Trond Ulven, Ashley M. Miller, Andrew B. Tobin and Graeme Milligan
    Molecular Pharmacology May 2016, 89 (5) 505-520; DOI: https://doi.org/10.1124/mol.115.101949
  • You have access
    Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling
    Xiongzhi Wangpu, Jiaoyang Lu, Ruxing Xi, Fei Yue, Sumit Sahni, Kyung Chan Park, Sharleen Menezes, Michael L.H. Huang, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
    Molecular Pharmacology May 2016, 89 (5) 521-540; DOI: https://doi.org/10.1124/mol.115.103044
  • A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
    Open Access
    A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
    David Stroebel, Derek L. Buhl, John D. Knafels, Pranab K. Chanda, Michael Green, Simone Sciabola, Laetitia Mony, Pierre Paoletti and Jayvardhan Pandit
    Molecular Pharmacology May 2016, 89 (5) 541-551; DOI: https://doi.org/10.1124/mol.115.103036
  • You have access
    Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss
    Ronald K. Freund, Emily S. Gibson, Huntington Potter and Mark L. Dell’Acqua
    Molecular Pharmacology May 2016, 89 (5) 552-559; DOI: https://doi.org/10.1124/mol.115.103085
  • You have access
    RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
    Sasmita Tripathy, John D Chapman, Chang Y Han, Cathryn A Hogarth, Samuel L.M. Arnold, Jennifer Onken, Travis Kent, David R Goodlett and Nina Isoherranen
    Molecular Pharmacology May 2016, 89 (5) 560-574; DOI: https://doi.org/10.1124/mol.116.103697
  • You have access
    Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator
    Ayman K. Hamouda, Farah Deba, Ze-Jun Wang and Jonathan B. Cohen
    Molecular Pharmacology May 2016, 89 (5) 575-584; DOI: https://doi.org/10.1124/mol.116.103341
  • You have access
    Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
    David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton
    Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 89 (5)
Molecular Pharmacology
Vol. 89, Issue 5
1 May 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Perspective
  • Accelerated Communication
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics